Anticholinesterase Activity of Histamine H2-Receptor Antagonists in the Dog: Their Possible Role in Gastric Motor Activity-Reference-Cited by-同舟云学术

Anticholinesterase Activity of Histamine H2-Receptor Antagonists in the Dog: Their Possible Role in Gastric Motor Activity

Published:2008-06-28 Issue:4 Volume:2 Page:273-280
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:

Author:

Mizumoto Akiyoshi,Fujimura Masaki,Iwanaga Yuji,Miyashita Naoshi,Yoshida Naoyuki,Kondo Yoichi,Itoh Zen

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2982.1990.tb00035.x/fullpdf

Reference27 articles.

1. Different effects of cimetidine and ranitidine on gastric emptying in rats and man;Scarpignato;Agents Actions,1982

2. Histamine H2-antagonists modify gastric emptying in the rat;Bertaccini;Br J Pharmacol,1982

3. Cholinergic-like effects of the new histamine H2-receptor antagonists ranitidine;Bertaccini;Agents Actions,1982

4. Further observations on the motor activity of some new histamine H2-receptor antagonists on the digestive system;Bertaccini;Int J Tissue React,1983

5. The inhibition of acetylcholinesterase and pseudocholinesterase by cimetidine;Hansen;Arzneimillelforschung/Drug Res,1983

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prokinetic Agents;Canine and Feline Gastroenterology;2013

2. Clinicopharmacological Study of Gastrointestinal Drugs from the Viewpoint of Postmarketing Development;YAKUGAKU ZASSHI;2006-09-01

3. Effect of gastric acidity regulation on the gastrointestinal transit time and secretion of gastric fluids in beagle dogs;Journal of Drug Delivery Science and Technology;2006

4. Gastrointestinal motility disorders and gastrointestinal prokinetic therapy;Veterinary Clinics of North America: Small Animal Practice;2003-09

5. Effects of histamine H2-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide;Journal of Pharmacy and Pharmacology;2002-11